Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714906 · ClinicalTrials.gov registry record · NA
Stellate Ganglion Block in Head and Neck Cancer Surgery
A NA study, sponsored by Augusta University.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03714906 is a NA study that was terminated before completion, run by Augusta University. The registered enrollment target is 22 participants.
The verdict
NCT03714906, a NA study, was terminated before completion, sponsored by Augusta University.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate and reduce pain and improve quality of life in patients being treated for head and neck cancer with unilateral surgery. In this study, patients will be randomly assigned to receive either pre-operative stellate ganglion block or no pre-operative treatment. Blocks will be placed by a trained anesthesiologist using ultrasound guidance in the preoperative holding area prior to surgery. All patients will receive the same post-operative pain medication regimen with appropriate pain treatment as needed. Patients will be asked to fill out surveys prior to surgery, while in the hospital after surgery, and at each follow-up appointment for up to 24 months.
Interventions
- PROCEDURE Stellate ganglion block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2022-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714906
The ClinicalTrials.gov registry entry for NCT03714906 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stellate ganglion block is the first listed.
NCT03714906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03714906 about?
NCT03714906 is a clinical study titled "Stellate Ganglion Block in Head and Neck Cancer Surgery". The purpose of this study is to evaluate and reduce pain and improve quality of life in patients being treated for head and neck cancer with unilateral surgery. In this study, patients will be randomly assigned to receive either pre-operative stellate ganglion block or no pre-operative treatment. Bl...
What is the current status of trial NCT03714906?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2019-03-22. Estimated completion is 2022-09-15.
What interventions are being tested in trial NCT03714906?
The interventions under investigation include: Stellate ganglion block (PROCEDURE).
Who is sponsoring clinical trial NCT03714906?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.